Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults
Clinical trial NCT02563093 · COMPLETED
Trial details
- NCT number
- NCT02563093
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2015-12-01
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.